Precoccious puberty during outpatient pamidronate therapy in type I Osteogenesis Imperfecta.

被引：0
|
作者：
Markello, TC
Boston, R
Steiner, R
机构：
[1] Samaritan Hlth Serv, Dept Pediat, Lebanon, OR USA
[2] Oregon Hlth Sci Univ, Portland, OR 97201 USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2002年 / 71卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
2400
引用
收藏
页码：579 / 579
页数：1
相关论文
共 50 条
  • [21] Intravenous Pamidronate in Osteogenesis Imperfecta Type VII
    Moira S. Cheung
    Francis H. Glorieux
    Frank Rauch
    Calcified Tissue International, 2009, 84 : 203 - 209
  • [22] Effect of cyclical intravenous pamidronate therapy in children with osteogenesis imperfecta. Open-label study in seven patients
    Giraud, F
    Meunier, PJ
    JOINT BONE SPINE, 2002, 69 (05) : 486 - 490
  • [23] Renal calculi in an infant with type III osteogenesis imperfecta.
    Shapiro, JR
    Porter, S
    Fivush, B
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S526 - S526
  • [24] Response to Pamidronate Therapy and Pharmacogenetics in Patients with Osteogenesis Imperfecta
    Selveindran, Nalini M.
    Hong, Janet Y. H.
    Nawawi, Nadiah Mohd
    Murad, Nor Azian Abdul
    Jamal, Rahman
    Latiff, Zarina Abdul
    Abd Aziz, Bilkis Banu
    Zakaria, Syed Zulkifli Syed
    Zain, Fuziah Md
    Rasat, Rahmah
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 197 - 197
  • [25] Impaired type I collagen C-telopeptide isomerization in patients with osteogenesis imperfecta.
    Garnero, P.
    Schott, A.
    Meunier, P. J.
    Chevrel, G.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S429 - S429
  • [26] EFFECT OF PAMIDRONATE ON BONE TURNOVER AND IGF-I IN TYPE-I OSTEOGENESIS IMPERFECTA
    SHAPIRO, JR
    COPLEY, C
    GOLDSBOROUGH, D
    GELMAN, R
    BARNHART, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S301 - S301
  • [27] Hammerhead ribozymes targeting glycine substitutions in type 1 collagen for the therapy of osteogenesis imperfecta.
    Smicun, Y
    Kilpatrick, MW
    Basel, D
    Wenstrup, RJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 622 - 622
  • [28] Increment of bone mass and diminution of bone fractures with oral pamidronate (APD) in children with osteogenesis imperfecta.
    Tau, CC
    Alvarez, V
    Mautalen, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S483 - S483
  • [29] The comparison of response to pamidronate treatment among children with osteogenesis imperfecta type I and III
    Shimizu, N
    Yamamura, S
    Satomura, K
    BONE, 2003, 32 (05) : S115 - S115
  • [30] Responsiveness to pamidronate treatment is not related to the genotype of type I collagen in patients with osteogenesis imperfecta
    Kanno, Junko
    Saito-Hakoda, Akiko
    Kure, Shigeo
    Fujiwara, Ikuma
    JOURNAL OF BONE AND MINERAL METABOLISM, 2018, 36 (03) : 344 - 351
12345